USD 455.8 million
Report ID:
SQMIG35A2814 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|Tables:
96
|Figures:
66
Global Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).
As per a report released by the National Institutes of Health (NIH), an estimated 10-15% of patients diagnosed with keratoconus necessitate undergoing a corneal implant procedure at some stage of their treatment. This underscores the significance of corneal implants in managing and addressing the impact of keratoconus, a condition that affects a notable portion of the population. Moreover, corneal blindness emerges as a substantial global health concern, ranking as the third-leading cause of blindness following glaucoma and cataract, with approximately 10 million people affected worldwide.
Global Market Size
USD 455.8 million
Largest Segment
Penetrating keratoplasty
Fastest Growth
Penetrating keratoplasty
Growth Rate
7.5% CAGR
To get more reports on the above market click here to Buy The Report
The corneal transplant market is segmented based on indication, type, end user, and region. Based on indications, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others. Based on type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty, corneal graft, corneal limbal stem cell transplant, and others. Based on end-user, the market is segmented into hospitals, eye clinics, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Analysis by Indication
The keratoconus category has emerged as the fastest-growing segment within the market, propelled by advancements in corneal implant procedures, notably Deep Anterior Lamellar Keratoplasty (DALK), and the presence of FDA-approved corneal implants. The innovative techniques associated with corneal implantation, such as DALK, have revolutionized the treatment landscape for keratoconus, offering patients more precise and tailored interventions. Additionally, the availability of FDA-approved corneal implants signifies a crucial endorsement of safety and efficacy, instilling confidence among healthcare providers and patients alike.
The fungal corneal ulcer category has emerged as the top revenue generator, constituting a substantial 70.4% share of the total market income. This dominance is primarily attributed to the increasing prevalence of fungal corneal ulcers, a trend particularly pronounced in the aging population that faces a higher risk of developing such ocular conditions. As individuals age, the immune system's efficacy may decline, making the elderly more susceptible to fungal infections, including those affecting the cornea.
Analysis by Type
The dominating force in the market, the penetrating keratoplasty segment, commands a significant 35% share of the total market revenue, equivalent to 0.14 billion. This method stands out as the standard approach for corneal transplant procedures due to its well-established safety profile and proven efficacy. Penetrating keratoplasty involves the complete replacement of the damaged or diseased cornea with a healthy donor cornea, addressing a range of cornea. The substantial market share attributed to this technique underscores its widespread acceptance and utilization within the medical community, affirming its status as a reliable and effective method for corneal transplantation.
Experiencing the most rapid growth within the market, the endothelial keratoplasty category stands out due to the availability of alternative forms that consistently exhibit favorable outcomes. This unique approach to corneal transplant distinguishes itself by selectively replacing only the affected endothelial tissue, as opposed to the entire thickness of the cornea. The increasing popularity and accelerated growth of endothelial keratoplasty underscore its effectiveness and advantages, contributing to its preference among both healthcare providers and patients.
To get detailed analysis on other segments, Request For Free Sample Report
North America is poised for dominance, driven by a rising awareness of eye donation initiatives in the region and the active involvement of numerous organizations. Within North America, the US corneal transplant market has secured the largest market share, underscoring its prominence in the industry. Simultaneously, the corneal transplant market in Canada has demonstrated the fastest growth in the region.
The Asia-Pacific corneal transplant market is anticipated to witness the most rapid Compound Annual Growth Rate (CAGR) from 2024 to 2031, driven by the escalating prevalence of ocular diseases attributable to lifestyle changes in the region. Factors such as diabetes, obesity, malnutrition, and other lifestyle-related illnesses have been associated with an increased incidence of vision impairments, fostering the demand for corneal transplant procedures. Notably, China has secured the largest market share within the corneal transplant market, highlighting its significant contribution to the regional landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Rising Prevalence of Eye Diseases
The primary catalyst propelling the corneal implant market is the significant rise in the prevalence of corneal disorders. Various conditions, including but not limited to keratoconus, Fuchs dystrophy, keratitis, corneal scarring, corneal ulcers, and corneal edema, necessitate corneal transplantation as a crucial therapeutic intervention. Notably, statistics from the Corneal Research Foundation of America reveal a substantial burden, with approximately 50 to 200 out of every 100,000 individuals grappling with the challenging corneal disorder, keratoconus. This prevalence underscores the escalating demand for corneal implants, as these devices play a pivotal role in addressing the diverse spectrum of corneal disorders. The growing incidence of these conditions underscores the pressing need for advanced treatment modalities, thereby fueling the expansion of the corneal implant industry.
Restraints
High Cost of Treatment
The corneal transplant market faces significant challenges with the high cost of treatment and a shortage of donor material emerging as key restraining factors to its growth. The expenses associated with corneal transplantation procedures, encompassing pre-operative assessments, surgical interventions, and post-operative care, contribute to the overall financial burden on patients and healthcare systems. The high cost may limit accessibility, particularly in regions with constrained healthcare resources.
Request Free Customization of this report to help us to meet your business objectives.
The competitive environment of the global Corneal Transplant market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The market is experiencing significant growth driven by several key factors. A notable contributor is the escalating prevalence of ophthalmic diseases, including conditions like keratoconus and infectious keratitis. This surge in disease prevalence has fueled the demand for advanced surgical interventions to address these eye conditions effectively. Moreover, there is a growing preference among consumers for minimally invasive surgical procedures, reflecting a broader trend in healthcare. The appeal of procedures that minimize trauma, reduce recovery times, and enhance overall patient comfort is driving the adoption of minimally invasive techniques in the field of ophthalmic surgery. Additionally, the rise in awareness regarding corneal transplants, with a focus on the aesthetic benefits they can provide, has further spurred market growth.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 455.8 million |
Market size value in 2031 | USD 873.88 million |
Growth Rate | 7.5% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Corneal Transplant Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Corneal Transplant Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Corneal Transplant Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Corneal Transplant Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2814
sales@skyquestt.com
USA +1 351-333-4748